Belgian biopharmaceutical company UCB has announced plans to build a $2 billion biologics manufacturing facility in Gwinnett ...
Moving away from fed-batch has significant sustainability and cost-saving benefits, according to industry working groups.
A federal court for the District of Massachusetts blocked several changes made to the childhood vaccination schedule by ...
Automation in cell and gene therapy manufacturing promises lower costs, improved efficiency, and expanded access to ...
Explore continuous processing and process intensification in biomanufacturing through hybrid models, workforce evolution, and ...
St. Jude interns share experiences in GMP manufacturing, highlighting SOPs, aseptic techniques, and collaboration in ...
Accelerate CGT developement with strategic viral vector manufacturing and CDMO partnerships that balance quality, cost, and ...
Scientists working in emerging modalities leverage robust quality systems & advanced analytical methods for development, ...
Explore the latest news and expert commentary by Tina Rogers, brought to you by the Contributor of BioProcess International.
Explore the latest news and expert commentary by Lior Shaltiel, brought to you by the Contributor of BioProcess International ...
The biotech firm says that its platform will help reduce the production costs of notoriously pricey gene therapies.
West conference in San Diego, California, this week, industry experts discussed how rapid advancements in AI technology are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results